Tiziana Life Sciences Ltd
TLSA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $5,229 | $8,113 | $12,955 | $13,208 |
| G&A Expenses | $0 | $0 | $0 | $855 |
| SG&A Expenses | $0 | $0 | $0 | $855 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $10,565 | $9,871 | $1,631 | $13,311 |
| Operating Expenses | $15,794 | $17,984 | $14,586 | $27,374 |
| Operating Income | -$15,794 | -$17,984 | -$14,586 | -$27,374 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$952 | $742 | -$811 | $717 |
| Pre-Tax Income | -$16,746 | -$17,242 | -$15,397 | -$26,657 |
| Tax Expense | -$4,883 | $449 | $0 | -$3,240 |
| Net Income | -$11,863 | -$17,691 | -$15,397 | -$23,417 |
| % Margin | – | – | – | – |
| EPS | -0.22 | -0.34 | -0.3 | -0.48 |
| % Growth | 35.3% | -13.3% | 37.5% | – |
| EPS Diluted | -0.22 | -0.34 | -0.3 | -0.48 |
| Weighted Avg Shares Out | 53,336 | 50,763 | 50,763 | 48,966 |
| Weighted Avg Shares Out Dil | 53,336 | 50,763 | 50,763 | 48,966 |
| Supplemental Information | – | – | – | – |
| Interest Income | $814 | $1,154 | $0 | $0 |
| Interest Expense | $6 | $10 | $7 | $176 |
| Depreciation & Amortization | $124 | $96 | $51 | $141 |
| EBITDA | -$16,616 | -$17,136 | -$15,339 | -$26,340 |
| % Margin | – | – | – | – |